ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
켈로이드 치료 시장 규모는 향후 수년간 안정된 성장이 전망됩니다. 2029년에는 CAGR 4.2%로 50억 9,000만 달러로 성장합니다. 예측 기간의 성장은 퍼스널케어 제품에 대한 지출 증가, 정부의 구상, 흉터 예방 전략에 대한 강조, 켈로이드 치료에 대한 투자 등에 기인합니다. 예측 기간의 주요 동향으로는 치료 방법의 발전, 의료 기술 혁신, 켈로이드 치료의 최소 침습 수술의 고도화, 병용 요법, 레이저 기술, 흉터 관리 제품 등을 들 수 있습니다.
향후 5년간 성장률 4.2%라는 예측은 지난번 예측보다 0.1% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 부과로 인해 미국에서는 독일과 한국에서 수입되는 실리콘 젤 시트와 냉동치료 장비에 대한 접근이 중단될 수 있으며, 흉터 관리의 성과가 악화되고 피부과 수술 비용이 증가할 수 있습니다. 또한 상호 관세와 무역 긴장의 증가와 제한으로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
상처와 부상 발생률 증가는 켈로이드 치료 시장의 성장을 가속할 것으로 예측됩니다. 상처는 신체 조직에 대한 물리적 손상이나 손상을 말하며, 일반적으로 사고, 수술, 화상, 기타 외상성 사건 등 다양한 요인으로 인한 피부의 파열을 동반합니다. 상처 증가는 켈로이드 형성에 기여하고, 효과적인 치료 옵션에 대한 수요를 증가시키고, 켈로이드 관련 합병증에 대한 인식을 높이고, 연구 발전을 촉진하고, 의료 전문가 간의 협력을 촉진합니다. 예를 들어 2023년 12월 미국 정부 기관인 노동통계국의 데이터에 따르면 2022년 미국내 사망 산업재해는 5,486건으로 2021년 5,190건보다 5.7% 증가했습니다. 이러한 증가 추세는 산업재해가 크게 증가하고 있음을 보여줍니다. 그 결과, 상처 및 부상 발생률 증가는 켈로이드 치료 시장의 확대를 촉진할 것으로 보입니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 켈로이드 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 켈로이드 치료 시장 : 성장률 분석
세계의 켈로이드 치료 시장 실적 : 규모와 성장, 2019-2024년
세계의 켈로이드 치료 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 켈로이드 치료 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 켈로이드 치료 시장 : 치료별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
방사선 치료
냉동요법
외과적 치료
레이저 치료
스테로이드 주사
인터페론
기타 치료
세계의 켈로이드 치료 시장 : 제품 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
탄성 랩
스프레이
연고
크림
오일
국소용 젤과 젤 시트
기타 제품
세계의 켈로이드 치료 시장 : 투여 경로별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
경구
비경구
세계의 켈로이드 치료 시장 : 최종사용자별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
병원
홈케어
피부과 클리닉
기타 최종사용자
세계의 켈로이드 치료 시장 : 서브 세분화 방사선 요법(유형별), 실적과 예측, 2019-2024년, 2024-2029년, 2034년
수술후 방사선 요법
수술전 방사선 요법
세계의 켈로이드 치료 시장 : 서브 세분화 냉동요법(유형별), 실적과 예측, 2019-2024년, 2024-2029년, 2034년
동결 수술
냉동 절제
세계의 켈로이드 치료 시장 : 서브 세분화 외과적 치료(유형별), 실적과 예측, 2019-2024년, 2024-2029년, 2034년
절제
재수술
세계의 켈로이드 치료 시장 : 서브 세분화 레이저 치료(유형별), 실적과 예측, 2019-2024년, 2024-2029년, 2034년
Fractional Laser
펄스 색소 레이저
세계의 켈로이드 치료 시장 : 서브 세분화 스테로이드 주사(유형별), 실적과 예측, 2019-2024년, 2024-2029년, 2034년
트리암시놀론 아세토나이드
베타메타존
세계의 켈로이드 치료 시장 : 서브 세분화 인터페론(유형별), 실적과 예측, 2019-2024년, 2024-2029년, 2034년
인터페론 알파
인터페론 감마
세계의 켈로이드 치료 시장 : 서브 세분화 기타 치료법(유형별), 실적과 예측, 2019-2024년, 2024-2029년, 2034년
실리콘 겔 시트
국소 치료
제7장 지역별·국가별 분석
세계의 켈로이드 치료 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 켈로이드 치료 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
켈로이드 치료 시장 : 경쟁 구도
켈로이드 치료 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
Novartis AG Overview, Products and Services, Strategy and Financial Analysis
Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
AstraZeneca plc
GlaxoSmithKline plc.
Eli Lilly and Company
Mylan N.V.
Galderma S.A.
Sun Pharmaceutical Industries Ltd.
Molnlycke Health Care AB
Cynosure Inc.
Cutera Inc.
Alliance Pharma plc
Revance Therapeutics Inc
Sensus Healthcare
Strata Skin Sciences
Avita Medical Limited
Pacific World Corporation
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
켈로이드 치료 시장 2029년 : 새로운 기회를 제공하는 국가
켈로이드 치료 시장 2029년 : 새로운 기회를 제공하는 부문
켈로이드 치료 시장 2029년 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Keloids refer to raised, thickened scars that extend beyond the original boundaries of a wound or injury. These scars result from an overgrowth of collagen during the healing process, leading to a firm, often discolored and sometimes uncomfortable or itchy area on the skin. Keloids can be treated using various medical interventions and approaches tailored to the individual's condition and the severity of the keloid.
The main types of keloids treatment are radiation therapy, cryotherapy, surgical treatment, laser treatment, steroid injections, interferon and others. Radiation therapy is a medical treatment that uses high doses of targeted radiation to target and destroy abnormal cells, such as keloid cells, aiming to inhibit the overgrowth of cells and reduce the size of keloids, which helps prevent keloid recurrence by damaging the cells that contribute to their formation. Keloids treatment also includes products such as elastic wraps, sprays, ointments, creams, oils, topical gels and gel sheets and others administered orally and parenterally by end users such as hospitals, homecare, dermatology clinics and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The keloids treatment market research report is one of a series of new reports from The Business Research Company that provides keloids treatment market statistics, including keloids treatment industry global market size, regional shares, competitors with a keloids treatment market share, detailed keloids treatment market segments, market trends and opportunities and any further data you may need to thrive in the keloids treatment industry. This keloids treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The keloids treatment market size has grown steadily in recent years. It will grow from $4.14 billion in 2024 to $4.32 billion in 2025 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to high prevalence of keloids, growing awareness keloid treatments, increasing incidence of wound and injury-related cases, rise in aesthetic surgeries.
The keloids treatment market size is expected to see steady growth in the next few years. It will grow to $5.09 billion in 2029 at a compound annual growth rate (CAGR) of 4.2%. The growth in the forecast period can be attributed to increasing expenditure on personal care products, government initiatives, increasing emphasis on scar prevention strategies, investments on keloids treatments. Major trends in the forecast period include advancements in treatment modalities, innovation in medical technologies, adanced minimally invasive procedures on keloids treatment, combination therapies, laser technology, scar management products.
The forecast of 4.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. access to silicone gel sheets and cryotherapy devices imported from Germany and South Korea, potentially worsening scar management outcomes and increasing dermatology procedure costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing incidence of wounds and injuries is expected to drive the growth of the keloid treatment market. A wound is a physical injury or damage to the body's tissues, typically involving a break in the skin, caused by various factors such as accidents, surgeries, burns, or other traumatic events. The rise in wound occurrences contributes to keloid formation, heightening the demand for effective treatment options, boosting awareness of keloid-related complications, encouraging research advancements, and fostering collaboration among medical professionals. For instance, in December 2023, data from the Bureau of Labor Statistics, a U.S. government agency, reported that fatal work injuries in the United States rose to 5,486 in 2022, representing a 5.7% increase from 5,190 in 2021. This upward trend highlights a substantial rise in industrial accidents. Consequently, the growing incidence of wounds and injuries will drive expansion in the keloid treatment market.
Growing interest in non-surgical aesthetic procedures is expected to drive the keloid treatment market. Non-surgical aesthetics are cosmetic treatments aimed at enhancing appearance without surgery, addressing specific concerns for a more youthful look. Healthcare providers utilize non-surgical procedures like laser therapy, cryotherapy, and dermal fillers to minimize the appearance and symptoms of keloid scars, reducing inflammation, redness, and vascularization. For example, in September 2023, the International Society of Aesthetic Plastic Surgery, a U.S.-based organization, reported that in 2022, plastic surgeons performed over 14.9 million surgical and 18.8 million non-surgical procedures globally, marking an 11.2% increase overall. Consequently, the rising demand for non-surgical aesthetic procedures will propel the keloid treatment market forward.
Prominent companies operating in the keloid treatment market are strategically focusing on the development of innovative scar management technologies, such as Scar Erase silicone strips, to attain a competitive edge. For instance, in April 2023, Scar Erase, a UK-based scar treatment company, introduced Scar Erase silicone strips as a solution for scar treatment. These strips, composed of 3 mm medical-grade silicone, have demonstrated clinical efficacy in enhancing scar appearance and facilitating healing. They are reusable, vegan, cruelty-free, and offer a convenient and cost-effective at-home scar treatment option suitable for various scar types, including hypertrophic, keloid, post-surgery, and stretch marks. The technology involves encapsulating the scar with silicone to maintain hydration and create an optimal healing environment. This approach reduces collagen formation, improves scar texture, color, and height, delivering both effectiveness and comfort.
In March 2022, Alliance Pharma PLC, a UK-based pharmaceutical company, completed the acquisition of ScarAway from Perrigo Co. PLC for $19.4 million. This acquisition empowered Alliance Pharma to strengthen its presence in the U.S. consumer healthcare market, diversify its product portfolio, establish a global brand, boost revenue, and solidify its position as a market leader in scar treatment. ScarAway, a U.S.-based scar treatment brand specializing in keloids, played a pivotal role in this strategic move.
Major companies operating in the keloids treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Eli Lilly and Company, Mylan N.V., Galderma S.A., Sun Pharmaceutical Industries Ltd., Molnlycke Health Care AB, Cynosure Inc., Cutera Inc., Alliance Pharma PLC, Revance Therapeutics Inc., Sensus Healthcare, Strata Skin Sciences, Avita Medical Limited, Pacific World Corporation, Mederma, Stratpharma AG, Sonoma Pharmaceuticals Inc., RXi Pharmaceuticals Inc., Biodermis, Novoxel Ltd., Scar Heal Inc., Galena Biopharma Inc.
North America was the largest region in the keloids treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in keloids treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the keloids treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, and Spain.
The keloids treatment market consists of revenues earned by entities by providing dermatology consultations, follow-up and monitoring and patient education and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The keloids treatment market also includes sales of topical creams and gels, silicone sheets and patches and dermal fillers, which are used in keloids treatment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Keloids Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on keloids treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for keloids treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The keloids treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Treatment: Radiation Therapy; Cryo Therapy; Surgical Treatment; Laser Treatment; Steroid Injections; Interferon; Other Treatments
2) By Product Type: Elastic Wraps; Sprays; Ointment; Creams; Oils; Topical Gels And Gel Sheets; Other Products
3) By Route Of Administration: Oral; Parenteral
4) By End User: Hospitals; Homecare; Dermatology Clinics; Other End Users
Subsegments:
1) By Radiation Therapy: Post-Surgical Radiation Therapy; Pre-Surgical Radiation Therapy
2) By Cryo Therapy: Cryosurgery; Cryoablation
3) By Surgical Treatment: Excision; Revision Surgery
4) By Laser Treatment: Fractional Laser; Pulsed Dye Laser
5) By Steroid Injections: Triamcinolone Acetonide; Betamethasone
6) By Interferon: Interferon-Alpha; Interferon-gamma
7) By Other Treatments: Silicone Gel Sheets; Topical Treatments
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG; Bristol-Myers Squibb Company; AstraZeneca plc; GlaxoSmithKline plc.; Eli Lilly and Company; Mylan N.V.; Galderma S.A.; Sun Pharmaceutical Industries Ltd.; Molnlycke Health Care AB; Cynosure Inc.; Cutera Inc.; Alliance Pharma plc; Revance Therapeutics Inc; Sensus Healthcare; Strata Skin Sciences; Avita Medical Limited; Pacific World Corporation; Mederma; Stratpharma AG; Sonoma Pharmaceuticals Inc.; RXi Pharmaceuticals Inc.; Biodermis; Novoxel Ltd.; Scar Heal Inc.; Galena Biopharma Inc.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Keloids Treatment Market Characteristics
3. Keloids Treatment Market Trends And Strategies
4. Keloids Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Keloids Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Keloids Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Keloids Treatment Market Growth Rate Analysis
5.4. Global Keloids Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Keloids Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Keloids Treatment Total Addressable Market (TAM)
6. Keloids Treatment Market Segmentation
6.1. Global Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Radiation Therapy
Cryo Therapy
Surgical Treatment
Laser Treatment
Steroid Injections
Interferon
Other Treatments
6.2. Global Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Elastic Wraps
Sprays
Ointment
Creams
Oils
Topical Gels And Gel Sheets
Other Products
6.3. Global Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
6.4. Global Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Dermatology Clinics
Other End Users
6.5. Global Keloids Treatment Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Post-Surgical Radiation Therapy
Pre-Surgical Radiation Therapy
6.6. Global Keloids Treatment Market, Sub-Segmentation Of Cryo Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cryosurgery
Cryoablation
6.7. Global Keloids Treatment Market, Sub-Segmentation Of Surgical Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Excision
Revision Surgery
6.8. Global Keloids Treatment Market, Sub-Segmentation Of Laser Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fractional Laser
Pulsed Dye Laser
6.9. Global Keloids Treatment Market, Sub-Segmentation Of Steroid Injections, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Triamcinolone Acetonide
Betamethasone
6.10. Global Keloids Treatment Market, Sub-Segmentation Of Interferon, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Interferon-Alpha
Interferon-gamma
6.11. Global Keloids Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Silicone Gel Sheets
Topical Treatments
7. Keloids Treatment Market Regional And Country Analysis
7.1. Global Keloids Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Keloids Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
